Haojun X. Chen
Xiamen Key Laboratory Of Radiopharmaceuticals, 55 Zhenhai Rd
Xiamen, 361003, China
Xiamen, 361003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 133 publications
Preclinical and first-in-human pilot evaluation of 177Lu-DOTA-7ND for fibroblast activation protein-α-targeted radionuclide imaging and therapy.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: June 03, 2026
Eco-Evolutionary Dynamics of Proliferation Heterogeneity: A Phenotype-Structured Model for Tumor Growth and Treatment Response.
Journal: Bulletin of mathematical biology
Published: April 27, 2026
Trop2-targeted PET/CT imaging with 68Ga-MY6349 improves diagnostic accuracy and influences clinical management in breast cancer.
Journal: Theranostics
Published: April 23, 2026
Early post-infarct fibroblast activation protein-targeted PET/CT with 68Ga-FAPI-46 identifies STEMI patients with preserved LVEF at higher risk for adverse remodeling and cardiovascular events.
Journal: European journal of nuclear medicine and molecular imaging
Published: April 15, 2026
A Prospective, Single-Center, Single-Arm, Exploratory Study of 177Lu-LNC1010 Peptide Receptor Radionuclide Therapy for Advanced Neuroendocrine Tumors.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: April 07, 2026
CXCR4-targeted PET/CT with [¹⁸F]AlF-NOTA-QHY-04 in primary central nervous system lymphoma: a prospective comparison with MRI and [¹⁸F]FDG PET/CT.
Journal: European journal of nuclear medicine and molecular imaging
Published: February 11, 2026
SparseTSF: Lightweight and Robust Time Series Forecasting via Sparse Modeling.
Journal: IEEE transactions on pattern analysis and machine intelligence
Published: August 25, 2025
Comparative analysis of 68Ga-FAPI-46 PET/CT and 18F-FDG PET/CT in advanced epithelial ovarian cancer: implications for preoperative scoring and treatment planning.
Journal: European journal of nuclear medicine and molecular imaging
Published: July 26, 2025
Preclinical and pilot clinical evaluation of novel dual-modality pet/fluorescence probes targeting FAP for accurate tumor margin delineation.
Journal: European journal of nuclear medicine and molecular imaging
Published: May 20, 2025
Prognostic value of multiparameter [68Ga]Ga-DOTA-FAPI-04 PET/MR imaging biomarkers for patients with advanced pancreatic cancer.
Journal: European journal of nuclear medicine and molecular imaging
Published: May 15, 2025
Last Updated: 09/26/2026